Hypoglycemia induced behavioural deficit and decreased GABA receptor, CREB expression in the cerebellum of streptozoticin induced diabetic rats

Brain Research Bulletin

Volumn 83, Issue 6, 2010, Pages 360-366

  Sherin, A ^a   Peeyush, K T ^a   Naijil, G ^a   Chinthu, R ^a   Paulose, C S ^a  

^a Department of Physics   (India)

Author keywords

Cerebellum; CREB; Diabetes; GABA receptor; Hypoglycemia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CEREBELLUM DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; HYPOGLYCEMIA; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; STREPTOZOCIN DIABETES; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; CEREBELLUM; CREB-BINDING PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MOVEMENT DISORDERS; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, GABA; RNA, MESSENGER; TRITIUM;

EID: 78149279965     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.09.004     Document Type: Article

References (62)

1. Abdelmalik P.A., Shannon P., Yiu A., Liang P., Adamchik Y., Weisspapir M., Samoilova M., Burnham W.M., Carlen P.L. Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction. Neurobiol. Dis. 2007, 26:646-660.
2. Abdul-Ghani A.S., Ghneim H., El-Lati S., Saca'an A. Changes in the activity of glutamate related enzymes in cerebral cortex, during insulin-induced seizures. Int. J. Neurosci. 1989, 44:67-74.
3. Anu J., Peeyush Kumar T., Nandhu M.S., Paulose C.S. Enhanced NMDAR1, NMDA2B and mGlu5 receptors gene expression in the cerebellum of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Eur. J. Pharmacol. 2010, 630:61-68.
4. Aragno M., Parola S., Tamagno E., Brignardello E., Manti R., Danni O., Boccuzzi G. Oxidative derangement in rat synaptosomes induced by hyperglycemia: restorative effect of dehydroepiandrosterone treatment. Biochem. Pharmacol. 2000, 60:389-395.
5. Auer R.N., Siesjo B.K. Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin. Endocrinol. Metab. 1993, 7:611-625.
6. Blumer D., Montouris G., Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav. 2004, 5:826-840.
7. Boyle P.J, Zrebiec J. Physiological and behavioral aspects of glycemic control and hypoglycemia in diabetes. South Med. J. 2007, 100:175-182.
8. Chang Y.C., Huang A.M., Kuo Y.M., Wang S.T., Chang Y.Y., Huang C.C. Febrile seizures impair memory and cAMP response-element binding protein activation. Ann. Neurol. 2003, 54:706-718.
9. Chen S., Kobayashi M., Honda Y., Kakuta S., Sato F., Kishi K. Preferential neuron loss in rat piriform cortex following pilocarpine induced status epilepticus. Epilepsy Res. 2007, 74:1-18.
10. Cryer P.E., Polonsky K.S. Glucose homeostasis and hypoglycemia. Williams Textbook of Endocrinology 1998, 939-971. W.B. Saunders Co., Philadelphia. 9th ed. J.D. Wilson, D.W. Foster (Eds.).
11. Dagogo-Jack S.E., Craft S., Cryer P.E. Hypoglycaemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycaemia reduces autonomic response to, symptoms of, and defense against subsequent hypoglycaemia. J. Clin. Invest. 1993, 91:819-828.
12. Deary I.J. Effects of hypoglycemia on cognitive function. Hypoglycemia and Diabetes: Clinical and Physiological Aspects 1993, 80-92. Edward Arnold, London. B.M. Frier, B.M. Fisher (Eds.).
13. Dean I., Robertson S.J., Edwards F.A. Serotonin drives a novel GABAergic synaptic current recorded in rat cerebellar purkinje cells: a Lugaro cell to Purkinje cell synapse. J. Neurosci. 2003, 23:4457-4469.
14. Diabetes Control and Complications Trial The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329:977-986.
15. Dickerson L.W., Bonthius D.J., Schutte B.C., Yang B., Barna T.J., Bailey M.C., Nehrke K., Williamson R.A., Lamb F.S. Altered GABAergic function accompanies hippocampal degeneration in mice lacking ClC-3 voltage-gated chloride channels. Brain Res. 2002, 958:227-250.
16. A receptor iso-oligomers. J. Biol. Chem. 1990, 265:3831-3835.
17. Duncan C.E., Webster M.J., Rothmond D.A., Bahn S., Elashoff M., Shannon W.C. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J. Psychiatr. Res. 2010, 44:673-681.
18. Ertl A.C., Davis S.N. Evidence for a vicious cycle of exercise and hypoglycaemia in type 1 diabetes mellitus. Diabetes Metab. Res. 2004, 20:124-130.
19. Flanagan D.E., Evans M.L., Monsod T.P., Rife F., et al. The influence of insulin on circulating ghrelin. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E313-E316.
20. Freund T.F., Buzsáki G. Alterations in excitatory and GABAergic inhibitory connections in hippocampal transplants. Neuroscience 1988, 27:373-385.
21. Fritschy J.M. Epilepsy, E/I Balance and GABA(A) Receptor Plasticity. Front. Mol. Neurosci 2008, 1:5.
22. Gazit V., Ben-Abraham R., Pick C., Ben-Shlomo I., Katz Y. Long-term neurobehavioral and histological damage in brain of mice induced by l-cysteine. Pharmacol. Biochem. Behav. 2003, 75:795-799.
23. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain: the disposition of [3H] norepinephrine, [3H] dopamine and [3H] DOPA in various regions of the brain. J. Neurochem. 1966, 13:655-669.
24. Gonder-Frederick L., Zrebiec J., Bauchowitz A., Lee J., Cox D., Ritterband L., Kovatchev B., Clarke W. Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents: a field study. Pediatrics 2008, 121:489-495.
25. Hausser M., Clark B.A. Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration. Neuron 1997, 19:665-678.
26. Hohenegger M., Rudas B. Kidney function in experimental diabetic ketosis. Diabetologia 1971, 7:334-338.
27. Hvidberg A., Fanelli C.G., Hershey T., Terkamp C., Craft S., Cryer P.E. Impact of recent antecedent hypoglycaemia on hypoglycaemic cognitive dysfunction in nondiabetic humans. Diabetes 1996, 46:1031-1036.
28. Ishige K., Ito Y., Fukuda H. Cyclic AMP responsive element- and activator protein 1 DNA-binding activities in epilepsy model mice. J. Pharm. Soc. Jpn. 1999, 119:510-518.
29. A receptor plasticity. Front. Mol. Neurosci. 2008, 10.3389/neuro.02.005.
30. Joseph A., Remya R., Paulose C.S. Enhanced [3H] glutamate binding in the cerebellum of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Cell. Mol. Neurobiol. 2007, 27:1085-1095.
31. Joseph A., Sherin A., Paulose C.S. Increased glutamate receptor gene expression in the cerebral cortex of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Neuroscience 2008, 156:298-304.
32. Junod A., Lambert A.E., Staufferacher W., Renold A.E. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest. 1969, 48:2129-2139.
33. A receptor channel function in the nervous system. Prog. Neurobiol. 1994, 42:489-537.
34. Kirchner A., Velískova J., Velisek L. Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur. J. Neurosci. 2006, 23:1512-1522.
35. Kleihues P., Kiessling M., Thilmann R., Xie Y., Uozumi A., Volk B. Resistance to hypoglycemia of cerebellar transplants in the rat forebrain. Acta Neuropathol. 1986, 72:23-28.
36. Kurioka S., Toshiaki k., Makoto M. Effect of sodium and bicarbonate ions on GABA receptor binding in synaptic membrane of rat brain. J. Neurochem. 1981, 37:418-421.
37. Low P.A., Nickander K.K., Tritschler H.J. The role of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46:38-42.
38. Lowry O.H., Roserbrough N.J., Farr A.L., Randall R.J. Protein measurements and folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
39. Luján R. Subcellular regulation of metabotropic GABA receptors in the developing cerebellum. Cerebell. 2007, 6:123-129.
40. A receptor channels. Annu. Rev. Neurosci. 1994, 17:569-602.
41. Mcnay E.C., Williamson A., Mccrimmon R.J., Sherwin R.S. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes 2006, 55:1088-1095.
42. Marshall J.F., Friedman M.I., Heffner T.G. Reduced anorexic and locomotor-stimulant action of d-amphetamine in alloxan-diabetic rats. Brain Res. 1976, 111:428-432.
43. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2001, 2:599-609.
44. Peeyush K.T., Savitha B., Sherin A., Anju T.R., Jes P., Paulose C.S. Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with vitamin D3 supplementation. Pharmacol. Biochem. Behav. 2010, 95:216-222.
45. Perlman S.L. Cerebellar ataxia. Curr. Treat. Options Neurol. 2000, 2:215-224.
46. Pi X., Lee J., Li F., Rosenberg H.C. Decreased expression of brain cAMP response element-binding protein gene following pentylenetetrazol seizure. Brain Res. Mol. Brain Res. 2004, 127:60-67.
47. Roberta M.K., Peter L.S. Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate. J. Neurosci. 2003, 23:8432-8444.
48. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor. Trends Neurosci. 1987, 10:299-302.
49. Saransaariand P., Simo S.O. Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus. Int. J. Dev. Neurosci. 1997, 15:163-174.
50. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 1949, 51:660-672.
51. Sherin A., Peeyush K.T., Mathew J., Anju T.R., Paulose C.S. Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats. J. Biomed. Sci. 2010, 5:17-21.
52. Shuaib A., Kanthan R. Amplification of inhibitory mechanisms in cerebral ischemia: an alternative approach to neuronal protection. Histol. Histopathol. 1997, 12:185-194.
53. Sophie F., Robert F.A., Tobin J.A. Long term increase of glutamate decarboxylase mRNA in a rat model of temporal lobe epilepsy. Neuron 1990, 5:361-371.
54. Takayama C., Inoue Y. Normal formation of the postsynaptic elements of GABAergic synapses in the reeler cerebellum. Brain Res. Dev. Brain Res. 2003, 145:197-211.
55. Thouvarecq R., Protais P., Jouen F., Caston J. Influence of cholinergic system on motor learning during aging in mice. Behav. Brain Res. 2001, 118:209-218.
56. Wasielewski P.G., Burns J.M., Koller W.C. Pharmacologic treatment of tremor. Mov. Disord. 1998, 3:90-100.
57. Wassmer E., Davies P., Whitehouse W.P., Stuart H. Clinical spectrum associated with cerebellar hypoplasia. Pediatr. Neurol. 2003, 28:347-351.
58. Wredling R.A., Theorell P.G., Roll H.M., Lins P.E., Adamson U.K. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care 1992, 15:518-521.
59. Yuji K., Toshihide T., Sho K., et al. Postsynaptic GABAB receptor signaling enhances LTD in mouse cerebellar Purkinje cells. J. Physiol. 2007, 585:549-563.
60. Zezula J., Cortes R., Probst A., Palacios J.M. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 1988, 25:771-795.
61. Z'Graggen W.J., Metz G.A., Kartje G.L., Thallmair M., Schwab M.E. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J. Neurosci. 1998, 18:4744-4757.
62. Zorumski C.F., Olney J.W. Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmacol. Ther. 1993, 59:145-162.